Company / PP&E per Share
Niagen Bioscience, Inc. PP&E per Share History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$0.02
FY2024
5-year range
$0.02 / $0.05
FY2020-FY2024
Trend
-20.0%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
PP&E per Share has declined for 5 consecutive years, from $68.34 in FY2019 to $0.02 in FY2024.
Based on SEC 10-K filings.
0.02 in FY2024 with a 5-year CAGR of -79.8%.
Declined from $0.04 to $0.02 over the past 2 years.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- -22.1%
- 5-Year CAGR
- -79.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- Niagen Bioscience, Inc.'s pp&e per share has declined for 5 consecutive years.
- In FY2024, pp&e per share decreased 20.0% year-over-year.
- Peak pp&e per share was recorded in FY2019.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $0.02 | -20.0% |
| FY2023 | $0.03 | -30.2% |
| FY2022 | $0.04 | -15.3% |
| FY2021 | $0.05 | -9.8% |
| FY2020 | $0.05 | -99.9% |
| FY2019 | $68.34 | +104173.6% |
| FY2018 | $0.07 | -14.3% |
| FY2017 | $0.08 | +54.9% |
| FY2016 | $0.05 | +190.7% |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026